European journal of cancer (Oxford, England : 1990)
Letter Re: TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma: signal or noise?
Luca Bertolaccini, Filippo de Marinis, Lorenzo Spaggiari
Published: 202510.1016/j.ejca.2025.116036
No abstract available for this study.